OPSITE Post-Op Visible Wound Dressings in Treatment of Surgical Incisions
OPOV
A Prospective, Open, Randomised Controlled Trial to Compare OPSITE Post-Op Visible Wound Dressings With Standard Therapy in the Treatment of Surgical Incisions.
1 other identifier
interventional
100
1 country
6
Brief Summary
OPSITE Post-Op Visible is a tri-layer dressing made up of a low adherent wound contact layer, lattice shaped absorbent pad and a top film that is waterproof and a bacterial barrier and is coated with a water-based adhesive. The comparator is a standard care treatment regime comprising tape and gauze. This study requires 100 eligible patients which will be recruited from the patients routinely see by the study investigators at each study site. Eligible patients will undergo surgery that results in a surgical wound of 27cm or less that is expected to have low or moderate levels of exudate and will have received at least one randomised study treatment. The primary objective is to compare OPOV and tape/gauze in terms of wear time per patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2011
Shorter than P25 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 12, 2012
CompletedFirst Posted
Study publicly available on registry
April 13, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedApril 26, 2017
April 1, 2013
5 months
April 12, 2012
April 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Average wear time per patient
Average wear time per patient = Sum of evaluation dressing wear times for a patient/number of dressing applications
0-14 days after surgery
Secondary Outcomes (14)
Dressing wear time
0-14 days after surgery
Infection
0-30 days after surgery
Clinical signs of infection
0-30 days after surgery
Dehiscence
0-14 days after surgery
Exudate management
0-14 days after surgery
- +9 more secondary outcomes
Study Arms (2)
OPSITE Post-Op Visible
EXPERIMENTALSubject is randomized to OPSITE Post-Op Visible group or Tape\&Gauze group. Dressing should be used right after surgery and changed as needed.
Tape&Gauze
ACTIVE COMPARATORSubject is randomized to OPSITE Post-Op Visible group or Tape\&Gauze group. Tape and Gauze should be used right after surgery and changed as per routin practice.
Interventions
Patient will be treated with OPSITE POST-OP VISIBLE dressing up to 14 days post surgery
Patient will be treated with tape and gauze up to 14 days post surgery
Eligibility Criteria
You may qualify if:
- Patients undergoing "clean surgery" in an operating room
- Patients whose wounds will be closed surgically and not left to heal by secondary intention.
- Patients who are in-patients and are expected to be so for at least 5 days or are willing to return to the site for dressing changes.
- Patients who are at least 18 years of age.Patients who understand the trial and are willing to consent to the trial
- Patients who are willing to attend the post-discharge follow-up assessment.
- Patients whose wounds are up to 27cm in length (as measured from end to end in a straight line)
- Patients whose wounds are expected to have low to moderate exudate.
You may not qualify if:
- Pregnant or lactating females
- Patients undergoing chemotherapy, radiation therapy or taking any medication which is known to adversely affect wound healing
- Patients with a known medical condition or status known to delay or prevent normal wound healing such as diabetes, HIV, collagen vascular disorders and primary immune disorders
- Patients with a known sensitivity to any components of the investigational products or other similar dressings/products
- Patients with a history of poor compliance with medical treatment
- Patients who have participated in the study and who healed or were withdrawn.
- Patients who are unable to understand the aims and objectives of the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
The First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 510080, China
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
Beijing Jishuitan Hospital
Beijing, 100035, China
Peking Union Medical College Hospital
Beijing, 100730, China
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, 200092, China
Shanghai Sixth People's Hospital
Shanghai, 200233, China
Study Officials
- STUDY CHAIR
Bingfang Zeng
Shanghai 6th People's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2012
First Posted
April 13, 2012
Study Start
November 1, 2011
Primary Completion
April 1, 2012
Study Completion
August 1, 2012
Last Updated
April 26, 2017
Record last verified: 2013-04
Data Sharing
- IPD Sharing
- Will not share